NBTY Acquires Leading UK Food Specialty Retailer Julian Graves
17 Settembre 2008 - 3:34PM
PR Newswire (US)
RONKONKOMA, N.Y., Sept. 17 /PRNewswire-FirstCall/ -- NBTY, Inc.
(NYSE:NTY) (http://www.nbty.com/), a leading global manufacturer
and marketer of nutritional supplements, today announced it has
acquired Julian Graves, the UK's largest independent specialty
natural food and ingredients retailer for approximately $25 million
USD. Julian Graves has a network of 350 stores nationwide with
annual sales of approximately $120 million USD. The acquisition
will expand NBTY's European Retail division from 638 stores to 983
stores. NBTY Chairman and CEO, Scott Rudolph, said: "The
acquisition of Julian Graves is an integral part of NBTY's
strategic plan to enhance its position as the number one supplement
retailer in the UK and gain greater market share. We continue to
seek acquisitions which generate growth and further entrench NBTY
as the worldwide leader in the nutritional supplement industry."
ABOUT NBTY NBTY is a leading global vertically integrated
manufacturer, marketer and distributor of a broad line of
high-quality, value-priced nutritional supplements in the United
States and throughout the world. Under a number of NBTY and third
party brands, the Company offers over 22,000 products, including
products marketed by the Company's Nature's Bounty(R)
(http://www.naturesbounty.com/), Vitamin World(R)
(http://www.vitaminworld.com/), Puritan's Pride(R)
(http://www.puritan.com/), Holland & Barrett(R)
(http://www.hollandandbarrett.com/), Rexall(R)
(http://www.rexall.com/), Sundown(R)
(http://www.sundownnutrition.com/), MET-Rx(R)
(http://www.metrx.com/), Worldwide Sport Nutrition(R)
(http://www.sportnutrition.com/), American Health(R)
(http://www.americanhealthus.com/), GNC (UK)(R)
(http://www.gnc.co.uk/), DeTuinen(R) (http://www.detuinen.nl/),
LeNaturiste(TM) (http://www.lenaturiste.com/), SISU(R)
(http://www.sisu.com/), Solgar(R) (http://www.solgar.com/), Good
'n' Natural(R) (http://www.goodnnatural.com/), Home Health(TM)
(http://www.homehealthus.com/) and Ester-C(R)
(http://www.ester-c.com/) brands. This release contains certain
forward-looking statements within the meaning of the Private
Securities Litigation Reform Act of 1995 with respect to our
financial condition, results of operations and business. These
forward-looking statements can be identified by the use of
terminology such as "subject to," "believe," "expects," "plan,"
"project," "estimate," "intend," "may," "will," "should," "can," or
"anticipates," or the negative thereof, or variations thereon, or
comparable terminology, or by discussions of strategy. Although all
of these forward-looking statements are believed to be reasonable,
they are inherently uncertain. Factors which may materially affect
such forward-looking statements include: (i) slow or negative
growth in the nutritional supplement industry; (ii) interruption of
business or negative impact on sales and earnings due to acts of
God, acts of war, terrorism, bio-terrorism, civil unrest or
disruption of mail service; (iii) adverse publicity regarding
nutritional supplements; (iv) inability to retain customers of
companies (or mailing lists) recently acquired; (v) increased
competition; (vi) increased costs; (vii) loss or retirement of key
members of management; (viii) increases in the cost of borrowings
and/or unavailability of additional debt or equity capital; (ix)
unavailability of, or inability to consummate, advantageous
acquisitions in the future, including those that may be subject to
bankruptcy approval or the inability of NBTY to integrate
acquisitions into the mainstream of its business; (x) changes in
general worldwide economic and political conditions in the markets
in which NBTY may compete from time to time; (xi) the inability of
NBTY to gain and/or hold market share of its wholesale and/or
retail customers anywhere in the world; (xii) unavailability of
electricity in certain geographical areas; (xiii) the inability of
NBTY to obtain and/or renew insurance and/or the costs of the same;
(xiv) exposure to and expense of defending and resolving product
liability and intellectual property claims and other litigation;
(xv) the ability of NBTY to successfully implement its business
strategy; (xvi) the inability of NBTY to manage its retail,
wholesale, manufacturing and other operations efficiently; (xvii)
consumer acceptance of NBTY's products; (xviii) the inability of
NBTY to renew leases for its retail locations; (xix) the inability
of NBTY's retail stores to attain or maintain profitability; (xx)
the absence of clinical trials for many of NBTY's products; (xxi)
sales and earnings volatility and/or trends for the Company and its
market segments; (xxii) the efficacy of NBTY's Internet and on-line
sales and marketing strategies; (xxiii) fluctuations in foreign
currencies, including the British pound, the Euro and the Canadian
dollar; (xxiv) import-export controls on sales to foreign
countries; (xxv) the inability of NBTY to secure favorable new
sites for, and delays in opening, new retail and manufacturing
locations; (xxvi) introduction of and compliance with new federal,
state, local or foreign legislation or regulation or adverse
determinations by regulators anywhere in the world (including the
banning of products) and more particularly Good Manufacturing
Practices in the United States, the Food Supplements Directive and
Traditional Herbal Medicinal Products Directive in Europe and
Section 404 requirements of the Sarbanes-Oxley Act of 2002; (xxvii)
the mix of NBTY's products and the profit margins thereon; (xxviii)
the availability and pricing of raw materials; (xxix) risk factors
discussed in NBTY's filings with the U.S. Securities and Exchange
Commission; (xxx) adverse effects on NBTY as a result of increased
energy prices and potentially reduced traffic flow to NBTY's retail
locations; (xxxi) adverse tax determinations; (xxxii) the loss of a
significant customer of the Company; (xxxiii) potential investment
losses as a result of liquidity conditions; and (xxxiv) other
factors beyond the Company's control. Readers are cautioned not to
place undue reliance on forward-looking statements. NBTY cannot
guarantee future results, trends, events, levels of activity,
performance or achievements. NBTY does not undertake and
specifically declines any obligation to update, republish or revise
forward-looking statements to reflect events or circumstances after
the date hereof or to reflect the occurrences of unanticipated
events. Consequently, such forward-looking statements should be
regarded solely as NBTY's current plans, estimates and beliefs.
Contact: Harvey Kamil Carl Hymans NBTY, Inc. G.S. Schwartz &
Co. President & Chief Financial Officer 212-725-4500
631-200-2020 DATASOURCE: NBTY, Inc. CONTACT: Harvey Kamil,
President & Chief Financial Officer of NBTY, Inc.,
+1-631-200-2020; or Carl Hymans of G.S. Schwartz & Co.,
+1-212-725-4500, , for NBTY, Inc. Web site: http://www.nbty.com/
Copyright
Grafico Azioni N B T Y (NYSE:NTY)
Storico
Da Giu 2024 a Lug 2024
Grafico Azioni N B T Y (NYSE:NTY)
Storico
Da Lug 2023 a Lug 2024